Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2022-01-07 00:00:00 ET · period of report 2021-12-31 · accession 0001209191-22-002471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-07 | 2021-12-31 | RLAY | Adams Brian | GC | A - Grant | $26.10 | +658 | 25.6K | +3% | +$17.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-31 | A | A | 658 | $26.10 | 25,647 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021. (F3) Includes 12,895 shares underlying RSUs. |